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In conventional microbial expression systems recombinant protein production (RPP) is typically growth
associated and therefore, metabolic resources are diverted into the formation of biomass rather than
heterologous product formation. Consequently, the expression of the protein of interest (POI) is always in direct
competition with the simultaneous production of host proteins by the transcription and translation machinery of
the cell. Most of the time this circumstance is unfavorable for achieving high yields of correctly folded
recombinant proteins and triggers adverse reactions of the host cell caused by a metabolic overburden of the
cell factory.
Inspired by phage derived regulation of the bacterial transcription machinery, we have engineered a phage T7based protein expression system for E. coli in which RPP is non-growth associated. This technology is based on
synthetic biology approach which improves the capacity of the bacterial host to express a POI by the partial
expression of a T7-derived Gp2 protein during the RPP phase. This non-DNA-binding transcription factor binds
the E. coli RNA polymerase and therefore prevents σ-factor 70 mediated formation of transcriptional qualified
open promoter complexes. Thereby, the transcription of host genes is inhibited, and metabolic resources can be
exclusively utilized for synthesis of the POI, which significantly improves RPP in industrial relevant process
conditions. We demonstrate that this expression technology, called enGenes-X-press, allows for extraordinary
high product yields and especially high specific amounts of correctly folded soluble recombinant protein in
standard fed-batch cultivations. Further we present our continuous 2-stage chemostat, driven by growth
decoupled protein production concept, that facilitates production of >100 g recombinant protein in 12 days with
benchtop equipment (1 L scale bioreactor).

Figure 1 Growth decoupled recombinant protein production in fed-batch (A) and 2-phase continuous bioprocess
(B). Upon induction Gp2 inhibits host mRNA production by binding to the ß’ jaw domain of host RNAP,
consequently leading to a stop of cell division and decoupling of protein production and cell growth.
Overexpression of the gene of interest is initiated by addition of IPTG and driven by the orthogonal T7 RNAP.
This approach allows clear separation of a RPP process into two phases to re-organize cellular metabolism to
become optimal for RPP. B) The growth decoupled protein production approach can be used in continuous
fermentation environment by establishing a 2-phase continuous bioprocess during RPP.

